Results 201 to 210 of about 17,544,570 (361)
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source
Evaluation of the effectiveness of standardized training for new nurses using the Kirkpatrick model: An observational study. [PDF]
Liu T, Ren Y, Wang X.
europepmc +1 more source
EVALUATION OF TWO SYNTHETIC CURARIZING AGENTS IN CONSCIOUS VOLUNTEERS [PDF]
R. I. Bodman
openalex +1 more source
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani+14 more
wiley +1 more source
Draft policy for Independent External Evaluation [PDF]
CGIAR Independent Evaluation Arrangement
core
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
Appendix B: Background and Concept Note on Evaluation in the CGIAR [PDF]
CGIAR Independent Evaluation Arrangement
core